Journals
Publish with us
Publishing partnerships
About us
Blog
The Breast Journal
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
The Breast Journal
/
2022
/
Article
/
Tab 1
/
Research Article
The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER−/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institute
Table 1
Relationship between the adjuvant therapy and the recurrence.
Adjuvant therapy
Recurrence 95% confidence interval
value
Hormonal therapy
0.004
Yes
78.31 (74.44–82.17)
No
72.772 (67.62–77.91)
Chemotherapy
0.000
Yes
71.287 (67.81–74.76)
No
85.663 (79.84–91.48)
Radiation
0.000
Yes
77.76 (73.82–81.70)
No
71.98 (67.01–76.95)
Neo-adjuvant chemotherapy
0.040
Yes
68.45 (61.38–75.53)
No
77.231 (74.00–80.45)